公司分别取得了阿奇霉素、克拉霉素、罗红霉素、盐酸苄丝肼的GMP证书，并取得了非诺贝特、格列美脲的COS证书。
公司主导产品红霉素系列产品阿奇霉素、克拉霉素、罗红霉素具有国内较大生产规模。
美罗培南、亚胺培南、比阿培南等碳青霉烯类抗生素，处于国内领先地位。 |
|
|
Macrolide antibiotics |
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Azithromycin dihydrate |
USP/ EP/ JP |
DMF |
117772-70-0 |
2 |
Azithromycin monohydrate |
USP |
TP |
|
3 |
Azithromycin pellet |
in-house |
TP |
|
4 |
Clarithromycin |
USP/ EP/ JP |
DMF (COS under access) |
81103-11-9 |
6 |
Clarithromycin pellet |
in-house |
DMF |
|
7 |
Roxithromycin |
EP/BP |
|
80214-83-1 |
|
|
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Biapenem |
in house |
|
120410-24-4 |
2 |
Ertapenem |
R&D |
|
153832-46-3 |
3 |
Imipenem &Cilastatin |
USP/EP |
DMF |
74431-23-5 |
4 |
Meropenem |
USP/CP |
DMF |
119478-56-7 |
|
Cardiovascular |
|
product |
pharmacopoeia |
regulatory documents |
CAS No. |
1 |
Ciprofibrate |
EP |
DMF |
52214-84-3 |
2 |
Benzafibrate |
EP |
TP |
41859-67-0 |
3 |
Fenofibrate |
EP |
DMF |
49562-28-9 |
4 |
carvedilol |
EP |
|
72956-09-3 |
|
Dopamine antagonist |
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Alizapride |
in-house |
TP |
59338-87-3 |
2 |
Amisulpride |
EP |
TP |
71675-85-9 |
3 |
Levosulpride |
in-house |
TP |
23672-07-3 |
4 |
Veralipride |
in-house |
DMF |
66644-81-3 |
Antidiabetic |
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Glimepiride |
EP |
DMF |
93479-97-1 |
2 |
Pioglitazone |
in house |
TP |
111025-46-8 |
3 |
Rosiglitazone |
in house |
TP |
122320-73-4 |
4 |
Repaglinide |
in house |
TP |
135062-02-1 |
Dermatology (retinoids) |
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Acitretin |
EP/USP |
TP |
55079-83-9 |
2 |
Etretinate |
In house |
TP |
54350-48-0 |
3 |
Isotretinoin |
EP/USP |
DMP |
4759-48-2 |
4 |
Tretinoin |
EP/USP |
DMP |
302-79-4 |
Antiparkinsonian |
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Benserazide hydrochloride |
EP |
DMF |
14919-77-8 |
2 |
Entacapone |
in house |
|
130929-57-6 |
3 |
Pramipexole |
in house |
|
104632-26-0 |
Asthma |
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Montelukast |
R & D |
|
151767-02-1 |
Antihyperphosphataemia |
|
product |
pharmacopoeia |
regulatory documentation |
CAS No. |
1 |
Sevelamer HCL |
in house |
|
152751-57-0 |
2 |
Sevelamer Carbonate |
in house |
|
845273-93-0 |
** Products including development, sales and offers are preformed where permissible by patent law,products covered by specific patent in certain countries are not offered for sale in such countries.
|
|
|
 |
